Search research articles
Contact Us
Filters
Showing results (11-20 of 161) with videos related to
Page
of 17
Sort By:
Current Opinion in Rheumatology
|
March 3, 2023
Antiphospholipid syndrome management: a 2023 update and practical algorithm-based approach
Amala Ambati, Jason S Knight, Yu Zuo
Current Opinion in Rheumatology
|
December 29, 2022
An update on inflammation in antiphospholipid syndrome
Amala Ambati, Yu Zuo, Jason S Knight
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 18, 2022
Reply
Hui Shi, Jason S Knight, Yogendra Kanthi
Current Rheumatology Reports
|
August 27, 2020
NETs in APS: Current Knowledge and Future Perspectives
Ajay Tambralli, Kelsey Gockman, Jason S Knight
Annals of the Rheumatic Diseases
|
November 1, 2016
Response to: 'Monocyte type I interferon signature in antiphospholipid syndrome is related to pro-inflammatory monocyte subsets, hydroxychloroquine and statin use' by van den Hoogen et al
Srilakshmi Yalavarthi, Robert C Grenn, Jason S Knight
Frontiers in Bioscience : a Journal and Virtual Library
|
February 28, 2002
The Epstein Barr nuclear antigen EBNA3C regulates transcription, cell transformation and cell migration
Chitra Subramanian, Jason S Knight, Erle S Robertson
BMJ Case Reports
|
February 12, 2020
Digital ischaemia secondary to adalimumab-induced antiphospholipid syndrome
Shashank Cheemalavagu, Sara S McCoy, Jason S Knight
Frontiers in Immunology
|
November 30, 2016
Intercellular Interactions as Regulators of NETosis
Nayef M Kazzaz, Gautam Sule, Jason S Knight
Molecular and Cellular Biology
|
February 17, 2005
SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen
Jason S Knight, Nikhil Sharma, Erle S Robertson
Proceedings of the National Academy of Sciences of the United States of America
|
December 15, 2005
Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase
Jason S Knight, Nikhil Sharma, Erle S Robertson
Page
of 17
Search research articles
Search
Showing results (11-20 of 161) with videos related to
Sort By:
Page
of 17
Current Opinion in Rheumatology
|
March 3, 2023
Antiphospholipid syndrome management: a 2023 update and practical algorithm-based approach
Amala Ambati, Jason S Knight, Yu Zuo
Current Opinion in Rheumatology
|
December 29, 2022
An update on inflammation in antiphospholipid syndrome
Amala Ambati, Yu Zuo, Jason S Knight
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 18, 2022
Reply
Hui Shi, Jason S Knight, Yogendra Kanthi
Current Rheumatology Reports
|
August 27, 2020
NETs in APS: Current Knowledge and Future Perspectives
Ajay Tambralli, Kelsey Gockman, Jason S Knight
Annals of the Rheumatic Diseases
|
November 1, 2016
Response to: 'Monocyte type I interferon signature in antiphospholipid syndrome is related to pro-inflammatory monocyte subsets, hydroxychloroquine and statin use' by van den Hoogen et al
Srilakshmi Yalavarthi, Robert C Grenn, Jason S Knight
Frontiers in Bioscience : a Journal and Virtual Library
|
February 28, 2002
The Epstein Barr nuclear antigen EBNA3C regulates transcription, cell transformation and cell migration
Chitra Subramanian, Jason S Knight, Erle S Robertson
BMJ Case Reports
|
February 12, 2020
Digital ischaemia secondary to adalimumab-induced antiphospholipid syndrome
Shashank Cheemalavagu, Sara S McCoy, Jason S Knight
Frontiers in Immunology
|
November 30, 2016
Intercellular Interactions as Regulators of NETosis
Nayef M Kazzaz, Gautam Sule, Jason S Knight
Molecular and Cellular Biology
|
February 17, 2005
SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen
Jason S Knight, Nikhil Sharma, Erle S Robertson
Proceedings of the National Academy of Sciences of the United States of America
|
December 15, 2005
Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase
Jason S Knight, Nikhil Sharma, Erle S Robertson
Page
of 17